RU2012114146A - Нерадиоактивные фосфолипидные соединения, композиции и способы их применения - Google Patents

Нерадиоактивные фосфолипидные соединения, композиции и способы их применения Download PDF

Info

Publication number
RU2012114146A
RU2012114146A RU2012114146/15A RU2012114146A RU2012114146A RU 2012114146 A RU2012114146 A RU 2012114146A RU 2012114146/15 A RU2012114146/15 A RU 2012114146/15A RU 2012114146 A RU2012114146 A RU 2012114146A RU 2012114146 A RU2012114146 A RU 2012114146A
Authority
RU
Russia
Prior art keywords
radioactive
group
iodine
cancer
compound
Prior art date
Application number
RU2012114146/15A
Other languages
English (en)
Russian (ru)
Inventor
Анатолий ПИНЧУК
Марк ЛОНДЖИНО
Джейми П. УЭЙЧЕРТ
Уилльям Р. КЛАРК
Абрам М. ВАККАРО
Иравати КАНДЕЛА
Original Assignee
Селлектар, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Селлектар, Инк. filed Critical Селлектар, Инк.
Publication of RU2012114146A publication Critical patent/RU2012114146A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0408—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2012114146/15A 2009-09-11 2010-09-10 Нерадиоактивные фосфолипидные соединения, композиции и способы их применения RU2012114146A (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US24175909P 2009-09-11 2009-09-11
US24176209P 2009-09-11 2009-09-11
US61/241,759 2009-09-11
US61/241,762 2009-09-11
US30918710P 2010-03-01 2010-03-01
US30921310P 2010-03-01 2010-03-01
US61/309,213 2010-03-01
US61/309,187 2010-03-01
PCT/US2010/048351 WO2011031919A2 (en) 2009-09-11 2010-09-10 Non-radioactive phospholipid compounds, compositions, and methods of use

Publications (1)

Publication Number Publication Date
RU2012114146A true RU2012114146A (ru) 2013-10-20

Family

ID=43730778

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012114146/15A RU2012114146A (ru) 2009-09-11 2010-09-10 Нерадиоактивные фосфолипидные соединения, композиции и способы их применения

Country Status (5)

Country Link
US (2) US20110064661A1 (enExample)
EP (1) EP2475400A2 (enExample)
JP (1) JP2013504590A (enExample)
RU (1) RU2012114146A (enExample)
WO (1) WO2011031919A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8540968B2 (en) 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
DE602005015687D1 (de) 2004-03-02 2009-09-10 Cellectar Inc Phospholipid-analoga für die behandlung von krebs
DK3708192T3 (da) * 2009-06-12 2023-11-06 Cellectar Inc Etherphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
WO2011031919A2 (en) * 2009-09-11 2011-03-17 Cellectar, Inc. Non-radioactive phospholipid compounds, compositions, and methods of use
CN107708702A (zh) * 2014-11-17 2018-02-16 塞勒克塔生物科学有限公司 磷脂醚类似物作为靶向癌症的药物载体
WO2019200017A1 (en) 2018-04-10 2019-10-17 Cellectar Biosciences, Inc. Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
MX2022003044A (es) * 2019-09-12 2022-06-02 Cellectar Biosciences Inc Conjugados de éter de fosfolípido como vehículos de fármacos que focalizan el cáncer.
KR102973364B1 (ko) 2019-10-10 2026-06-04 셀렉타 바이오사이언시스, 인코퍼레이티드 인지질-플라바글린 접합체 및 표적화된 암 치료를 위해 이를 사용하는 방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925649A (en) * 1987-06-12 1990-05-15 The University Of Michigan Radioiodinated diacylglycerol analogues and methods of use
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5347030A (en) * 1987-10-23 1994-09-13 The Board Of Regents Of The University Of Michigan Radioiodinated phospholipid ether analogues and methods of using same
US5087721A (en) * 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5626654A (en) * 1995-12-05 1997-05-06 Xerox Corporation Ink compositions containing liposomes
WO1998024480A1 (en) * 1996-12-04 1998-06-11 The Regents Of The University Of Michigan Radioiodinated phospholipid ether analogs and methods of using the same
US6255519B1 (en) * 1996-12-04 2001-07-03 Regents Of The University Of Michigan Radioiodinated phospholipid ether analogs and methods of using the same
US6503478B2 (en) * 1999-01-13 2003-01-07 Lightouch Medical, Inc. Chemically specific imaging of tissue
US7220539B1 (en) * 2002-06-12 2007-05-22 The Salk Institute For Biological Studies Protein kinase B/Akt modulators and methods for the use thereof
US8540968B2 (en) * 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
WO2006014589A2 (en) * 2004-07-08 2006-02-09 Cellectar, Llc Virtual colonoscopy with radiolabeled phospholipid ether analogs
DE602005015687D1 (de) * 2004-03-02 2009-09-10 Cellectar Inc Phospholipid-analoga für die behandlung von krebs
US7632644B2 (en) * 2004-03-02 2009-12-15 Cellectar, Inc. Imaging and selective retention of phospholipid ether analogs
EP1729790A4 (en) * 2004-03-29 2009-09-30 Robin Polt AMPHIPATHIC GLYCOPEPTIDES
US20060115426A1 (en) * 2004-08-11 2006-06-01 Weichert Jamey P Methods of detecting breast cancer, brain cancer, and pancreatic cancer
US7041859B1 (en) * 2004-09-09 2006-05-09 University Of Tennessee Research Foundation Method for halogenating or radiohalogenating a chemical compound
MX2007007497A (es) * 2004-12-20 2008-01-11 Cellectar Llc Analogos de fosfolipido eter para la deteccion y tratamiento del cancer.
WO2009005509A1 (en) * 2006-08-15 2009-01-08 Cellectar, Inc. Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications
US7893286B2 (en) * 2007-06-01 2011-02-22 Cellectar, Inc. Method for the synthesis of phospholipid ethers
DK3708192T3 (da) * 2009-06-12 2023-11-06 Cellectar Inc Etherphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
WO2011031919A2 (en) * 2009-09-11 2011-03-17 Cellectar, Inc. Non-radioactive phospholipid compounds, compositions, and methods of use
WO2011031911A1 (en) * 2009-09-11 2011-03-17 Cellectar, Inc. Deuterated alkyl phospholipid compounds, compositions, and methods of use

Also Published As

Publication number Publication date
EP2475400A2 (en) 2012-07-18
JP2013504590A (ja) 2013-02-07
US20120156133A1 (en) 2012-06-21
WO2011031919A2 (en) 2011-03-17
US20110064661A1 (en) 2011-03-17
WO2011031919A3 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
EP3484513B1 (en) Radiohalogenated agents for combined cancer therapy
JP2013504590A5 (enExample)
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
JP2012158602A5 (enExample)
KR101848131B1 (ko) 저용량 이리노테칸염산염 수화물을 함유하는 항종양제
US8507710B2 (en) Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
CA2453687A1 (en) Therapeutic composition containing at least diflomotecan and capecitabin e
HRP20150030T1 (hr) Derivati pirazolokinolina kao inhibitori dna-pk
JP2016522202A (ja) メトホルミン及びジヒドロケルセチンを含む組み合わせ医薬、及びがんの治療のための使用
HRP20220520T1 (hr) Ciklički dinukleotidi kao agensi protiv raka
CN113015529A (zh) 用于癌症治疗的免疫调节的组合
WO2018022571A1 (en) Targeted radiotherapy chelates for in situ immune modulated cancer vaccination
MX2024014994A (es) Macrociclos de indazol y su uso
RU2009124622A (ru) Новые гидрофильные производные 2-арил-4-хинолонов в качестве противораковых агентов
MX2024009858A (es) Compuestos y radioligandos para direccion al receptor de neurotensina y usos de los mismos
JP2010514734A (ja) 腸障害の治療のためのイソソルビドモノニトレート誘導体
AR045811A1 (es) 5- arilpirimidinas como agentes ainticancerigenos
RU2004135307A (ru) Производное эпотилона для лечения гепатомы и других раковых заболеваний
KR20130118981A (ko) 다형 교모세포종의 치료를 위한 마시텐탄 포함 조합물
EP2890374B1 (en) Compositions and methods for drug-sensitization or inhibition of a cancer cell
RU2010120810A (ru) Гидратированные кристаллические сложные эфиры камптотецина для лечения рака
ES2503735T3 (es) Complejos de tricarbonilo de renio que comprenden aminoácidos como ligandos bidentados y su uso como agentes quimiotóxicos radioterápicos
KR102694803B1 (ko) A-노르-5α안드로스테인 화합물계 약물 및 항암제의 병용
ES2747073T3 (es) Combinación de RO5503781, capecitabina y oxaliplatino para el tratamiento del cáncer
JP2020516612A (ja) 癌の治療のための化合物、組成物およびその使用